About Protein Z-dependent protease inhibitor
Protein Z-dependent protease inhibitor (SERPINA10) is a protein
from Homo sapiens identified by UniProt accession
Q9UK55, 444 residues long.
MolForge cross-references it against 0 known binders and
54 disease associations.
Target properties
| Protein name | Protein Z-dependent protease inhibitor |
| UniProt accession | Q9UK55 |
| Gene | SERPINA10 |
| Organism | Homo sapiens |
| Length | 444 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (54)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.32
- low density lipoprotein cholesterol measurement · score 0.17
- total cholesterol measurement · score 0.08
- platelet count · score 0.06
- apolipoprotein B measurement · score 0.06
- total iron binding capacity · score 0.05
- colorectal cancer · score 0.04
- esophageal adenocarcinoma · score 0.03
- deep vein thrombosis · score 0.02
- neoplasm · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UK55-F1 | alphafold | PREDICTED | 86.73 | — |
Amino-acid sequence (444 residues)
MKVVPSLLLS VLLAQVWLVP GLAPSPQSPE TPAPQNQTSR VVQAPKEEEE DEQEASEEKA SEEEKAWLMA SRQQLAKETS NFGFSLLRKI SMRHDGNMVF SPFGMSLAMT GLMLGATGPT ETQIKRGLHL QALKPTKPGL LPSLFKGLRE TLSRNLELGL TQGSFAFIHK DFDVKETFFN LSKRYFDTEC VPMNFRNASQ AKRLMNHYIN KETRGKIPKL FDEINPETKL ILVDYILFKG KWLTPFDPVF TEVDTFHLDK YKTIKVPMMY GAGKFASTFD KNFRCHVLKL PYQGNATMLV VLMEKMGDHL ALEDYLTTDL VETWLRNMKT RNMEVFFPKF KLDQKYEMHE LLRQMGIRRI FSPFADLSEL SATGRNLQVS RVLQRTVIEV DERGTEAVAG ILSEITAYSM PPVIKVDRPF HFMIYEETSG MLLFLGRVVN PTLL
Explore Protein Z-dependent protease inhibitor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets